دورية أكاديمية

New insights on mucormycosis and its association with the COVID-19 pandemic.

التفاصيل البيبلوغرافية
العنوان: New insights on mucormycosis and its association with the COVID-19 pandemic.
المؤلفون: Alshahawey MG; Department of Clinical Pharmacy, Faculty of Pharmacy, Ain Shams University, Cairo, 11566, Egypt., El-Housseiny GS; Department of Microbiology & Immunology, Faculty of Pharmacy, Ain Shams University, Cairo, 11566, Egypt., Elsayed NS; Department of Microbiology & Immunology, Faculty of Pharmacy, Ain Shams University, Cairo, 11566, Egypt., Alshahrani MY; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, 9088, Saudi Arabia., Wakeel LM; Department of Clinical Pharmacy, Faculty of Pharmacy, Ain Shams University, Cairo, 11566, Egypt., Aboshanab KM; Department of Microbiology & Immunology, Faculty of Pharmacy, Ain Shams University, Cairo, 11566, Egypt.
المصدر: Future science OA [Future Sci OA] 2021 Dec 16; Vol. 8 (2), pp. FSO772. Date of Electronic Publication: 2021 Dec 16 (Print Publication: 2022).
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Future Science Group Country of Publication: England NLM ID: 101665030 Publication Model: eCollection Cited Medium: Print ISSN: 2056-5623 (Print) Linking ISSN: 20565623 NLM ISO Abbreviation: Future Sci OA Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: London : Future Science Group, [2015]-
مستخلص: COVID-19 continues to cause significant fatality worldwide. Glucocorticoids prove to play essential roles in COVID-19 management; however, the extensive use of steroids together with the virus immune dysregulation may increase the danger of secondary infections with mucormycosis, an angioinvasive fungal infection. Unfortunately, a definite correlation between COVID-19 and elevated mucormycosis infection cases is now clear worldwide. In this review, we discuss the historical record and epidemiology of mucormycosis as well as pathogenesis and associated host immune response, risk factors, clinical presentation, diagnosis and treatment. Special emphasis is given to its association with the current COVID-19 pandemic, including latest updates on COVID-19-associated mucormycosis cases globally, with recommendations for efficacious management.
Competing Interests: Financial & competing interests disclosure The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. No writing assistance was utilized in the production of this manuscript.
(© 2021 Khaled M. Aboshanab.)
References: Rev Infect Dis. 1989 Sep-Oct;11(5):741-54. (PMID: 2682947)
Clin Microbiol Rev. 2000 Apr;13(2):236-301. (PMID: 10756000)
Int J Dermatol. 2010 Oct;49(10):1111-20. (PMID: 20883401)
J Antimicrob Chemother. 2015 Nov;70(11):3116-23. (PMID: 26316385)
J Fungi (Basel). 2021 Apr 24;7(5):. (PMID: 33923333)
Clin Infect Dis. 2000 Jun;30(6):851-6. (PMID: 10852735)
Mycoses. 2018 Jul;61(7):485-497. (PMID: 29611227)
Mycol Res. 2007 May;111(Pt 5):509-47. (PMID: 17572334)
Leuk Lymphoma. 2001 Sep-Oct;42(5):1119-23. (PMID: 11697631)
Clin Microbiol Infect. 2011 Dec;17(12):1859-67. (PMID: 21199154)
Am J Med. 1989 Oct;87(4):468-71. (PMID: 2679077)
J Fungi (Basel). 2019 Nov 14;5(4):. (PMID: 31739583)
Ann Intern Med. 1980 Jul;93(1):93-108. (PMID: 6772062)
J Infect Dis. 2009 Oct 1;200(7):1176-9. (PMID: 19698079)
Ann Thorac Surg. 2014 Nov;98(5):1832-5. (PMID: 25441799)
Indian J Med Microbiol. 2021 Jul;39(3):380-383. (PMID: 34052046)
Lancet. 2003 Nov 29;362(9398):1828-38. (PMID: 14654323)
Chest. 2000 Jan;117(1):279-82. (PMID: 10631232)
Infect Immun. 1995 Nov;63(11):4489-94. (PMID: 7591090)
N Engl J Med. 2012 Dec 6;367(23):2214-25. (PMID: 23215557)
J Clin Microbiol. 2010 Jun;48(6):2154-70. (PMID: 20357218)
Mycoses. 2020 Oct;63(10):1060-1068. (PMID: 32485012)
J Fungi (Basel). 2021 Jan 27;7(2):. (PMID: 33513875)
Mycopathologia. 2021 May;186(2):289-298. (PMID: 33544266)
Leuk Lymphoma. 2001 Nov-Dec;42(6):1393-9. (PMID: 11911424)
J Fungi (Basel). 2017 Sep 05;3(3):. (PMID: 29371565)
Mycoses. 2021 Aug;64(8):798-808. (PMID: 33590551)
Auris Nasus Larynx. 2010 Jun;37(3):322-8. (PMID: 19857939)
Med Mycol. 2019 Jun 1;57(4):395-402. (PMID: 30085158)
Front Microbiol. 2020 Mar 20;11:440. (PMID: 32265876)
J Clin Microbiol. 1999 Jun;37(6):1732-8. (PMID: 10325316)
J Fungi (Basel). 2018 Jan 18;4(1):. (PMID: 29371507)
Cureus. 2020 Sep 30;12(9):e10726. (PMID: 33145132)
Antimicrob Agents Chemother. 2019 Jul 25;63(8):. (PMID: 31182532)
Mycoses. 2014 Apr;57(4):240-6. (PMID: 24147728)
J Fungi (Basel). 2021 Oct 07;7(10):. (PMID: 34682258)
J Antimicrob Chemother. 2012 Mar;67(3):715-22. (PMID: 21937481)
J Clin Invest. 2010 Jun;120(6):1914-24. (PMID: 20484814)
Medicine (Baltimore). 1986 Mar;65(2):113-23. (PMID: 3951358)
Transplant Proc. 2014 Jul-Aug;46(6):1849-51. (PMID: 25131052)
Mycoses. 2021 Jul;64(7):780-787. (PMID: 33835599)
Transplantation. 2002 Feb 15;73(3):476-80. (PMID: 11884949)
J Clin Invest. 1984 Jul;74(1):150-60. (PMID: 6736246)
Eur J Clin Microbiol Infect Dis. 2001 Jul;20(7):460-6. (PMID: 11561801)
Surv Ophthalmol. 1994 Jul-Aug;39(1):3-22. (PMID: 7974189)
J Infect. 2001 May;42(4):261-6. (PMID: 11545569)
Br J Radiol. 2021 Nov 1;94(1127):20210648. (PMID: 34618551)
Antimicrob Agents Chemother. 2007 Jul;51(7):2587-90. (PMID: 17452481)
Am J Emerg Med. 2021 Apr;42:264.e5-264.e8. (PMID: 32972795)
Mycoses. 2014 Dec;57 Suppl 3:56-66. (PMID: 25179042)
J Antimicrob Chemother. 2012 Aug;67(8):1937-40. (PMID: 22535624)
Arch Pathol Lab Med. 2001 Mar;125(3):375-8. (PMID: 11231486)
Indian J Ophthalmol. 2018 Oct;66(10):1513-1516. (PMID: 30249859)
mBio. 2014 Jul 08;5(4):e01390-14. (PMID: 25006230)
J Infect Public Health. 2020 Dec;13(12):2080-2086. (PMID: 31248814)
Mycoses. 2013 Nov;56(6):638-45. (PMID: 23551865)
Persoonia. 2013 Jun;30:11-47. (PMID: 24027345)
Clin Microbiol Infect. 2005 Jul;11(7):515-7. (PMID: 15966968)
Clin Infect Dis. 2008 Aug 15;47(4):503-9. (PMID: 18611163)
Transpl Infect Dis. 2014 Aug;16(4):658-65. (PMID: 24962170)
Med Mycol. 2000;38 Suppl 1:243-50. (PMID: 11204152)
Clin Microbiol Infect. 2004 Mar;10 Suppl 1:31-47. (PMID: 14748801)
Emerg Infect Dis. 2009 Sep;15(9):1395-401. (PMID: 19788806)
Int J Infect Dis. 2021 Mar;104:287-292. (PMID: 33207271)
Biochim Biophys Acta. 2013 Aug;1828(8):1794-801. (PMID: 23562405)
Ann Pharmacother. 2016 Sep;50(9):747-57. (PMID: 27307416)
Infect Dis Clin North Am. 2006 Sep;20(3):581-607, vi. (PMID: 16984870)
J Craniomaxillofac Surg. 2012 Oct;40(7):584-91. (PMID: 22082732)
Auris Nasus Larynx. 2009 Jun;36(3):274-9. (PMID: 18786790)
JAMA. 2020 Oct 6;324(13):1330-1341. (PMID: 32876694)
Infect Immun. 1982 Dec;38(3):1123-9. (PMID: 6818145)
Mycoses. 2016 Jul;59(7):402-15. (PMID: 26906121)
Otolaryngol Clin North Am. 2000 Apr;33(2):323-34. (PMID: 10736407)
Curr Opin Microbiol. 2011 Aug;14(4):406-11. (PMID: 21807554)
PLoS Pathog. 2017 Aug 3;13(8):e1006408. (PMID: 28771587)
Med Mycol. 2018 Jan 1;56(1):29-43. (PMID: 28431008)
Antimicrob Agents Chemother. 2001 Dec;45(12):3487-96. (PMID: 11709329)
Clin Infect Dis. 2012 Feb;54 Suppl 1:S35-43. (PMID: 22247443)
J Fungi (Basel). 2019 Mar 14;5(1):. (PMID: 30875744)
Clin Infect Dis. 2020 Sep 12;71(6):1367-1376. (PMID: 31802125)
J Infect Dis. 2005 Apr 1;191(7):1180-7. (PMID: 15747255)
Arch Ophthalmol. 1997 Jul;115(7):919-21. (PMID: 9230837)
J Plast Reconstr Aesthet Surg. 2009 Nov;62(11):e434-41. (PMID: 18684680)
Postgrad Med J. 2009 Nov;85(1009):573-81. (PMID: 19892892)
Biochem Pharmacol. 1994 May 18;47(10):1843-50. (PMID: 8204101)
Laryngoscope. 1980 Apr;90(4):635-48. (PMID: 7359982)
Med Mycol. 2006 Jun;44(4):335-42. (PMID: 16772227)
BMJ Case Rep. 2021 Apr 27;14(4):. (PMID: 33906877)
Future Microbiol. 2014;9(5):683-95. (PMID: 24957094)
J Infect Public Health. 2020 Nov;13(11):1774-1779. (PMID: 32891591)
J Infect Dis. 1984 Nov;150(5):752-60. (PMID: 6387001)
Arch Intern Med. 1999 Jun 28;159(12):1301-9. (PMID: 10386506)
Br J Ophthalmol. 2016 Feb;100(2):184-8. (PMID: 26112869)
Interdiscip Perspect Infect Dis. 2014;2014:562610. (PMID: 25210515)
Support Care Cancer. 2006 Jul;14(7):783-6. (PMID: 16482446)
PLoS One. 2017 Jun 7;12(6):e0179136. (PMID: 28591186)
J Clin Invest. 1993 May;91(5):1979-86. (PMID: 8486769)
Microb Pathog. 2020 Oct;147:104382. (PMID: 32663605)
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102146. (PMID: 34192610)
Clin Microbiol Infect. 2015 May;21(5):490.e1-10. (PMID: 25677259)
Nat Commun. 2018 Aug 20;9(1):3333. (PMID: 30127354)
N Engl J Med. 1999 Mar 11;340(10):764-71. (PMID: 10072411)
Clin Microbiol Infect. 2009 Jul;15(7):693-7. (PMID: 19624514)
Microorganisms. 2021 Mar 04;9(3):. (PMID: 33806386)
J Clin Invest. 2014 Jan;124(1):237-50. (PMID: 24355926)
Immunobiology. 2013 Jul;218(7):939-44. (PMID: 23201314)
J Fungi (Basel). 2019 Mar 21;5(1):. (PMID: 30901907)
Infect Dis Clin North Am. 2002 Dec;16(4):895-914, vi. (PMID: 12512186)
Int J Infect Dis. 2010 Sep;14 Suppl 3:e100-3. (PMID: 20335060)
Emerg Infect Dis. 2010 Sep;16(9):1456-8. (PMID: 20735932)
J Fungi (Basel). 2021 Feb 25;7(3):. (PMID: 33668990)
Haematologica. 2000 Oct;85(10):1068-71. (PMID: 11025599)
Pediatr Infect Dis J. 2004 Aug;23(8):769-73. (PMID: 15295229)
Int J Med Microbiol. 2002 Oct;292(5-6):373-80. (PMID: 12452283)
JAMA Otolaryngol Head Neck Surg. 2020 Oct 1;146(10):964-966. (PMID: 32701126)
Nepal J Epidemiol. 2021 Jun 30;11(2):1034-1039. (PMID: 34290893)
Med Mycol. 2014 Jan;52(1):73-80. (PMID: 23848229)
Clin Microbiol Infect. 2019 Jan;25(1):26-34. (PMID: 30036666)
Mycologia. 2016 Sep;108(5):1028-1046. (PMID: 27738200)
Med Mycol. 2014 Nov;52(8):819-25. (PMID: 25288654)
Med Hypotheses. 2021 Jul;152:110613. (PMID: 34087613)
Med Mycol. 2018 Apr 1;56(suppl_1):93-101. (PMID: 29538730)
Trop Med Int Health. 2021 Sep;26(9):1016-1018. (PMID: 34117677)
J Antimicrob Chemother. 1991 Jul;28 Suppl A:13-22. (PMID: 1938703)
Clin Infect Dis. 2005 Sep 1;41(5):634-53. (PMID: 16080086)
Lancet Infect Dis. 2019 Dec;19(12):e405-e421. (PMID: 31699664)
Ear Nose Throat J. 1998 Mar;77(3):207-10, 215. (PMID: 9557411)
J Am Med Assoc. 1957 Mar 9;163(10):805-8. (PMID: 13405736)
J Infect. 2021 Aug;83(2):237-279. (PMID: 34029629)
Infect Immun. 1985 May;48(2):458-63. (PMID: 3157647)
Antimicrob Agents Chemother. 2015 Aug;59(8):4914-8. (PMID: 26055378)
J Mycol Med. 2018 Jun;28(2):269-273. (PMID: 29545123)
Clin Infect Dis. 2012 Feb;54 Suppl 1:S8-S15. (PMID: 22247451)
J Laryngol Otol. 2021 May;135(5):442-447. (PMID: 33827722)
Immunol Ser. 1989;47:243-71. (PMID: 2490078)
Clin Infect Dis. 2006 Aug 15;43(4):e29-38. (PMID: 16838223)
Am J Clin Pathol. 2007 Feb;127(2):208-12. (PMID: 17210526)
Trends Microbiol. 2003 Jun;11(6):272-9. (PMID: 12823944)
Mycoses. 2021 Sep;64(9):1028-1037. (PMID: 34133816)
Clin Infect Dis. 2012 Feb;54 Suppl 1:S23-34. (PMID: 22247442)
Infection. 2018 Dec;46(6):811-821. (PMID: 30121719)
Mycoses. 2001;44(7-8):253-60. (PMID: 11714058)
Antimicrob Agents Chemother. 2005 Feb;49(2):721-7. (PMID: 15673756)
Clin Microbiol Rev. 2005 Jul;18(3):556-69. (PMID: 16020690)
Am J Med Sci. 1998 Jul;316(1):39-45. (PMID: 9671042)
J Fungi (Basel). 2021 Feb 28;7(3):. (PMID: 33670842)
J Clin Microbiol. 1997 Jun;35(6):1353-60. (PMID: 9163443)
Transplantation. 2000 Jan 15;69(1):70-5. (PMID: 10653383)
Res Immunol. 1998 May-Jun;149(4-5):478-88; discussion 515. (PMID: 9720965)
J Gerontol A Biol Sci Med Sci. 2020 Sep 16;75(9):1788-1795. (PMID: 32279081)
Mycoses. 2015 Oct;58 Suppl 5:51-7. (PMID: 26449507)
Mycoses. 2019 Nov;62(11):984-989. (PMID: 30983046)
Lancet Infect Dis. 2016 Jul;16(7):828-837. (PMID: 26969258)
PLoS One. 2010 Sep 23;5(9):e12955. (PMID: 20886035)
Diabetes Res Clin Pract. 2002 Aug;57(2):139-42. (PMID: 12062859)
Clin Infect Dis. 2008 Jun 15;46(12):1813-21. (PMID: 18462102)
Antimicrob Agents Chemother. 2008 Feb;52(2):722-4. (PMID: 18025115)
J Clin Microbiol. 2021 Aug 18;59(9):e0123021. (PMID: 34232068)
Clin Infect Dis. 1997 Feb;24(2):192-6. (PMID: 9114146)
Clin Microbiol Infect. 2014 Jun;20 Suppl 6:60-6. (PMID: 24476149)
J Fungi (Basel). 2017 Oct 18;3(4):. (PMID: 29371573)
Chest. 1999 Dec;116(6):1818-20. (PMID: 10593814)
Clin Infect Dis. 2009 Jun 15;48(12):1743-51. (PMID: 19435437)
فهرسة مساهمة: Keywords: COVID-19; epidemiology; fungal infection; host immune response; mucormycosis
تواريخ الأحداث: Date Created: 20220121 Latest Revision: 20220219
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC8686842
DOI: 10.2144/fsoa-2021-0122
PMID: 35059222
قاعدة البيانات: MEDLINE
الوصف
تدمد:2056-5623
DOI:10.2144/fsoa-2021-0122